ScienceDaily (Aug. 29, 2007) — The Johns Hopkins scientist who first showed that the absence of the protein myostatin leads to oversized muscles in mice and men has now found a second protein, follistatin, whose overproduction in mice lacking myostatin doubles the muscle-building effect.

Results of the new study by Se-Jin Lee, M.D., Ph.D., in PloS One, show that while mice that lack the gene that makes myostatin have roughly twice the amount of body muscle as normal, mice without myostatin that also overproduce follistatin have about four times as much muscle as normal mice.

Lee, a professor of molecular biology and genetics, says this added muscle increase could significantly boost research efforts to “beef up” livestock or promote muscle growth in patients with muscular dystrophy and other wasting diseases.

Specifically, Lee first discovered that follistatin was capable of blocking myostatin activity in muscle cells grown under lab conditions. When he gave it to normal mice, the rodents bulked up, just as would happen if the myostatin gene in these animals was turned off.

He then genetically engineered a mouse that both lacked myostatin and made extra follistatin. If follistatin was increasing muscle growth solely by blocking myostatin, then Lee surmised that follistatin would have no added effect in the absence of myostatin.

“To my surprise and delight, there was an additive effect,” said Lee, who notes that these muscular mice averaged a 117 percent increase in muscle fiber size and a 73 percent increase in total muscle fibers compared to normal mice.

“These findings show that the capacity for increasing muscle growth by targeting these pathways is much more extensive than we have appreciated,” adds Lee. “Now we’ll search for other players that cooperate with myostatin so we can tap the full potential for enhancing muscle growth for clinical applications.”

Lee adds that this issue is of particular significance, as most agents targeting this pathway, including one drug being currently tested in a muscular dystrophy clinical trial, have been designed to block only myostatin and not other related proteins.

The research was funded by grants from the NIH and the Muscular Dystrophy Association and by a gift from Merck Research Laboratories.

Comparison of body and muscle size between normal mice (left) and double mutant mice lacking myostatin and overproducing follistatin (right. (Credit: Image courtesy of Johns Hopkins Medical Institutions)

Related Stories

Protein Causes Muscle Wasting Syndrome In Mice; Possible Clue To Treatments For Muscular Dystrophy, Other Conditions (May 27, 2002) — The Johns Hopkins researchers who first identified myostatin as a key restrictor of muscle growth in animals now report that excessive amounts of the protein in mice cause rapid and dramatic loss of ...  > read more

Muscle Gene Influences Fat Storage In Mice; May Be Target To Prevent Or Treat Obesity And Diabetes (Mar. 1, 2002) — For mice genetically altered to get fat, knocking out a particular gene keeps them both leaner and healthier, Johns Hopkins School of Medicine scientists report in the March 1 issue of the Journal of ...  > read more

"Mighty Mice" Gene Is Mutated In Beefy Bovines (Nov. 13, 1997) — The same genetic "secret formula" that gave unusually large muscles to the "mighty mice" engineered by Johns Hopkins is also at work naturally in specially bred cattle that have extra ...  > read more

'Mighty Mouse' Helping Find Ways To Prevent Osteoporosis (Sep. 15, 2004) — A genetically engineered 'mighty mouse' is helping Medical College of Georgia researchers find the best way for young people to build bone and avoid ...  > read more

Search ScienceDaily

Helping Cancer Survivors Grow Up